What You See is What You Get? Imaging of Cell Therapy for Cardiac Regeneration

被引:0
作者
Napp L.C. [1 ,3 ]
Templin C. [2 ]
机构
[1] Department of Cardiology and Angiology, Hannover Medical School, Hannover
[2] Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich
[3] Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School, Hannover
关键词
BLI; Heart failure; Imaging; MRI; Myocardial infarction; PET; SPECT; Stem cells;
D O I
10.1007/s12410-013-9243-z
中图分类号
学科分类号
摘要
An estimated 7.3 million people die from coronary heart disease each year, according to the recent report of the World Health Organization. In the hope of true regeneration of the infarcted or failing heart, stem and progenitor cells from various sources have gained massive attention in recent years. Data from animal and human studies have been conflicting, and cell type and application varied significantly across all protocols. It now has become clear that many details of cardiac cell therapy remain to be elucidated. In this context comprehensive in vivo imaging methods are essential tools to evaluate mechanisms of cell engraftment and function. In the present review we summarize current imaging modalities for tracking transplanted cells in animals and humans including most recent developments in the field. © 2014, Springer Science+Business Media New York.
引用
收藏
页码:1 / 11
页数:10
相关论文
共 62 条
  • [1] Roger V.L., Go A.S., Lloyd-Jones D.M., Et al., Heart disease and stroke statistics–2012 update: a report from the American Heart Association, Circulation, 125, pp. e2-e220, (2012)
  • [2] West N.E., The Year in Cardiology 2012: acute coronary syndromes, Eur Heart J, 34, pp. 422-426, (2013)
  • [3] Costopoulos C., Latib A., Naganuma T., Sticchi A., Giannini F., Colombo A., Newly available and recent advances in drug-eluting stents, Expert Rev Cardiovasc Ther, 11, pp. 555-566, (2013)
  • [4] Wollert K.C., Drexler H., Cell therapy for the treatment of coronary heart disease: a critical appraisal, Nat Rev Cardiol, 7, pp. 204-215, (2010)
  • [5] Shiba Y., Fernandes S., Zhu W.Z., Et al., Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts, Nature, 489, pp. 322-325, (2012)
  • [6] Houtgraaf J.H., den Dekker W.K., van Dalen B.M., Et al., First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction, J Am Coll Cardiol, 59, pp. 539-540, (2012)
  • [7] Wang L., Deng J., Tian W., Et al., Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts, Am J Physiol Heart Circ Physiol, 297, pp. H1020-H1031, (2009)
  • [8] Makkar R.R., Smith R.R., Cheng K., Et al., Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial, Lancet, 379, pp. 895-904, (2012)
  • [9] Brenner W., Aicher A., Eckey T., Et al., 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model, J Nucl Med, 45, pp. 512-518, (2004)
  • [10] Chen S.L., Fang W.W., Ye F., Et al., Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction, Am J Cardiol, 94, pp. 92-95, (2004)